Use este identificador para citar ou linkar para este item:
http://hdl.handle.net/1843/61926
Tipo: | Artigo de Periódico |
Título: | Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells |
Autor(es): | Ana Delia Pinzón García Rubén Dario Sinisterra Millán María Esperanza Cortés Segura Fredy Mesa Sandra Ramírez-Clavijo |
Resumo: | Breast cancer is the second leading cause of death in women, and tamoxifen citrate (TMX) is accepted widely for the treatment of hormone receptor–positive breast cancers. Several local drug-delivery systems, including nanofibers, have been developed for antitumor treatment. Nanofibers are biomaterials that mimic the natural extracellular matrix, and they have been used as controlled release devices because they enable highly efficient drug loading. The purpose of the present study was to develop polycaprolactone (PCL) nanofibers incorporating TMX for use in the treatment of breast tumors. Pristine PCL and PCL-TMX nanofibers were produced by electrospinning and characterized physiochemically using different techniques. In addition, an in vitro study of TMX release from the nanofibers was performed. The PCL-TMX nanofibers showed sustained TMX release up to 14 h, releasing 100% of the TMX. The Resazurin reduction assay was used to evaluate the TMX cytotoxicity on MCF-7 breast cancer cell line and PBMCs human. The PCL-TMX nanofiber was cytotoxic toPBMCs and MCF-7. Based on these results, the PCL-TMX nanofibers developed have potential as an alternative for local chronic TMX use for breast cancer treatment, however tissue tests must be done. |
Assunto: | Bioquímica Bioengenharia Biotecnologia farmacêutica Mamas - Câncer Câncer - Tratamento Receptores hormonais Tecnologia de liberação controlada |
Idioma: | eng |
País: | Brasil |
Editor: | Universidade Federal de Minas Gerais |
Sigla da Instituição: | UFMG |
Departamento: | FAO - DEPARTAMENTO DE ODONTOLOGIA RESTAURADORA ICX - DEPARTAMENTO DE QUÍMICA |
Tipo de Acesso: | Acesso Aberto |
Identificador DOI: | https://doi.org/10.7717/peerj.12124 |
URI: | http://hdl.handle.net/1843/61926 |
Data do documento: | 2021 |
metadata.dc.url.externa: | https://peerj.com/articles/12124/ |
metadata.dc.relation.ispartof: | PeerJ |
Aparece nas coleções: | Artigo de Periódico |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells.pdf | 1.04 MB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.